Clinical Trial Update: Accelerated Radio-Immunotherapy for Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on accelerated radio-immunotherapy for stage III non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Center Eugene Marquis | Conditions: Non Small Cell Lung Cancer Stage III | Phase 2 | Status: COMPLETED